Intragenic ERBB2 kinase mutations in tumours
Nature2004Vol. 431(7008), pp. 525–526
Citations Over TimeTop 1% of 2004 papers
Philip Stephens, Chris Hunter, Graham R. Bignell, Sarah Edkins, Helen Davies, Jon W. Teague, Claire Stevens, Sarah O’Meara, Raffaella Smith, Adrian G. Parker, Andy Barthorpe, Matthew J. Blow, Lisa Brackenbury, Adam P. Butler, Oliver B. Clarke, Jennifer Cole, Ed Dicks, Angus Dike, Anja Drozd, Ken Edwards, Simon Forbes, Rebecca R. Foster, Kristian Gray, Chris Greenman, Kelly Halliday, Katy Hills, Vivienne Kosmidou, Richard Lugg, Andy Menzies, Janet Perry, Robert Petty, Keiran Raine, Lewis Ratford, Rebecca Shepherd, Alexandra Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S. Cooper, Adrienne M. Flanagan, Margaret A. Knowles, Suet Yi Leung, David N. Louis, Leendert H. J. Looijenga, Bruce Malkowicz, Marco A. Pierotti, Bin Tean Teh, Georgia Chenevix‐Trench, Barbara L. Weber, Siu Tsan Yuen, Grace Harris, Peter Goldstraw, Andrew G. Nicholson, P. Andrew Futreal, Richard Wooster, Michael R. Stratton
Related Papers
- → High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets(2004)119 cited
- → Conservation and Early Expression of Zebrafish Tyrosine Kinases Support the Utility of Zebrafish as a Model for Tyrosine Kinase Biology(2012)21 cited
- → Receptor and nonreceptor tyrosine kinases in vascular biology of hypertension(2010)22 cited
- → The First 3D Model of the Full-Length KIT Cytoplasmic Domain Reveals a New Look for an Old Receptor(2020)9 cited
- → Abstract PL04-03: Cell signaling by receptor tyrosine kinases: From basic principles to cancer therapy(2012)1 cited